Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05092412Phase 2Active Not Recruiting
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
DurvalumabExtensive-stage Small-cell Lung CancerLung Cancer
StudydirectorStart date: 2022-03-02

Research Network

Collaboration Network

10 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Henan Provincial People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

You Lu, MD

West China Hospital

Moderately Similar
18 trials

Shared therapeutic areas:

Extensive-stage Small-cell Lung CancerLung CancerDurvalumab

Worked with same sponsors:

AstraZenecaYou Lu
Collaborated on 1 trial
Similarity Score34%

Lu Lu Su, MD

Henan Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

DurvalumabExtensive-stage Small-cell Lung CancerLung Cancer

Worked with same sponsors:

AstraZenecaYou Lu
Collaborated on 1 trial
Similarity Score34%

Yue Xie, MM

Chongqing University Cancer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

DurvalumabExtensive-stage Small-cell Lung CancerLung Cancer

Worked with same sponsors:

AstraZenecaYou Lu
Collaborated on 1 trial
Similarity Score34%

Shu Jie Li, MM

Chongqing University Cancer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

DurvalumabExtensive-stage Small-cell Lung CancerLung Cancer

Worked with same sponsors:

AstraZenecaYou Lu
Collaborated on 1 trial
Similarity Score34%

Sirilak Suksompong, MD

Mahidol University

Related
17 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05092412Phase 2StudyDirector

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

DurvalumabExtensive-stage Small-cell Lung CancerLung Cancer
Active Not Recruiting

All 1 trials loaded